TRIUMF

TRIUMF

Canada’s particle accelerator research facility

Overview

TRIUMF is Canada’s national particle accelerator centre in Vancouver, running a large accelerator complex for research in particle and nuclear physics. Researchers use its facilities to study fundamental matter and to develop practical technologies, including medical isotopes and materials science applications. It differentiates itself through nationwide university collaborations, a multidisciplinary team, and a direct path from basic discoveries to real-world benefits. Its goal is to advance science while building Canadian leadership in science and technology and training the next generation of scientists, engineers, and leaders.

Significant Headcount Growth

About TRIUMF

Simplify's Rating
Why TRIUMF is rated
B
Rated A on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Company Size

501-1,000

Company Stage

Grant

Total Funding

$293.2M

Headquarters

Vancouver, Canada

Founded

1968

Get referred to TRIUMF

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • BC’s $32 million cancer investment expands PET/CT capacity from 16,000 to 41,000 scans.
  • TRIUMF’s July 2026 benchmark strengthens grant leverage for advanced neutron and antimatter programs.
  • The 2025 CERN statement and 2026 summer-student pipeline reinforce TRIUMF’s talent and partnership moat.

What critics are saying

  • TRIUMF depends on public funding; the 2024 federal package and 2025 ministerial support dominate budgets.
  • Health Canada licensing and 2026 commissioning for the cyclotron can delay cancer-research revenue.
  • A failed nEDM or isotope program would weaken TRIUMF’s scientific relevance and funding case.

What makes TRIUMF unique

  • TRIUMF’s 2026 ultracold neutron source leads the world with 6.7×10⁵ neutrons per second.
  • Canada’s CERN partnership and TRIUMF-ATLAS work keep TRIUMF embedded in global physics networks.
  • TRIUMF’s UBC campus location anchors isotope science beside BC Cancer and Health Canada licensing.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$293.2M

Above

Industry Average

Funded Over

1 Rounds

Grant funding comparison data is currently unavailable. We're working to provide this information soon!
Grant Funding Comparison
Coming Soon

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Wellness Program

Parental Leave

Paid Vacation

Growth & Insights and Company News

Headcount

6 month growth

12%

1 year growth

12%

2 year growth

12%
SNOLAB
May 21st, 2025
Former SNOLAB director elected Fellow of the Royal Society

Smith left SNOLAB in 2021 to take on the role of executive director and CEO of TRIUMF in Vancouver.

Government of British Columbia
Jan 30th, 2024
BC Gov News

The Province is investing $32 million to support this work through $21 million to BC Cancer for the new cyclotron and radiopharmacy laboratory and approximately $11 million to TRIUMF to advance research.

Recently Posted Jobs

Sign up to get curated job recommendations

TRIUMF is Hiring for 7 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →